Dizal (jiangsu) Pharmaceutical Co., Ltd.

This study tests a new combination of two oral drugs, DZD6008 and sunvozertinib, in 160 adults with advanced non-small cell lung cancer that has certain EGFR mutations. The goal is to check safety, how the drugs move through the body, and whether they shrink tumors. It is the fir…

This study tests a daily pill called sunvozertinib against a placebo in 360 people with a specific type of lung cancer (stage IB-IIIA) who have had surgery to remove their tumor. The goal is to see if the drug can stop the cancer from returning. Participants must have certain EGF…